(Reuters) – The U.S. health regulator on Wednesday approved Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the country.
(Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber)
